Sone Capital Management LLC Makes New $18.07 Million Investment in The Cooper Companies, Inc. (NASDAQ:COO)

Sone Capital Management LLC bought a new position in The Cooper Companies, Inc. (NASDAQ:COO - Free Report) during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor bought 196,565 shares of the medical device company's stock, valued at approximately $18,070,000. Cooper Companies makes up about 2.3% of Sone Capital Management LLC's holdings, making the stock its 7th largest position. Sone Capital Management LLC owned about 0.10% of Cooper Companies as of its most recent SEC filing.

A number of other institutional investors have also recently made changes to their positions in the company. Covestor Ltd increased its stake in Cooper Companies by 35.5% in the 4th quarter. Covestor Ltd now owns 458 shares of the medical device company's stock worth $42,000 after buying an additional 120 shares during the period. Shell Asset Management Co. boosted its position in Cooper Companies by 15.5% in the 4th quarter. Shell Asset Management Co. now owns 946 shares of the medical device company's stock valued at $87,000 after buying an additional 127 shares during the period. Torray Investment Partners LLC grew its stake in Cooper Companies by 0.8% in the 4th quarter. Torray Investment Partners LLC now owns 16,190 shares of the medical device company's stock worth $1,488,000 after acquiring an additional 132 shares in the last quarter. Mather Group LLC. grew its stake in Cooper Companies by 7.4% in the 4th quarter. Mather Group LLC. now owns 1,926 shares of the medical device company's stock worth $177,000 after acquiring an additional 133 shares in the last quarter. Finally, MassMutual Private Wealth & Trust FSB increased its position in shares of Cooper Companies by 15.6% during the fourth quarter. MassMutual Private Wealth & Trust FSB now owns 1,008 shares of the medical device company's stock worth $93,000 after acquiring an additional 136 shares during the period. Hedge funds and other institutional investors own 24.39% of the company's stock.

Analysts Set New Price Targets

COO has been the topic of several research reports. Needham & Company LLC restated a "hold" rating on shares of Cooper Companies in a research note on Thursday. Citigroup cut their target price on shares of Cooper Companies from $115.00 to $110.00 and set a "buy" rating on the stock in a research report on Friday, March 7th. Piper Sandler restated an "overweight" rating and issued a $115.00 price target (down previously from $120.00) on shares of Cooper Companies in a report on Friday, March 7th. Stifel Nicolaus dropped their price objective on shares of Cooper Companies from $115.00 to $105.00 and set a "buy" rating on the stock in a research note on Friday, March 7th. Finally, BNP Paribas raised shares of Cooper Companies to a "hold" rating in a report on Thursday, March 13th. Three investment analysts have rated the stock with a hold rating and eight have issued a buy rating to the company. According to MarketBeat, the company currently has an average rating of "Moderate Buy" and a consensus price target of $110.25.

Cooper Companies Trading Down 0.6%

COO traded down $0.47 during trading hours on Friday, reaching $78.83. The company's stock had a trading volume of 1,548,951 shares, compared to its average volume of 1,490,340. The stock has a market cap of $15.76 billion, a PE ratio of 40.43, a P/E/G ratio of 2.25 and a beta of 1.08. The Cooper Companies, Inc. has a fifty-two week low of $69.81 and a fifty-two week high of $112.38. The company has a debt-to-equity ratio of 0.32, a current ratio of 1.91 and a quick ratio of 1.12. The business's 50-day moving average is $80.25 and its 200-day moving average is $89.34.

Cooper Companies (NASDAQ:COO - Get Free Report) last announced its quarterly earnings results on Thursday, March 6th. The medical device company reported $0.92 EPS for the quarter, meeting the consensus estimate of $0.92. The business had revenue of $964.70 million for the quarter, compared to analyst estimates of $981.25 million. Cooper Companies had a return on equity of 9.38% and a net margin of 10.07%. As a group, equities research analysts predict that The Cooper Companies, Inc. will post 3.98 earnings per share for the current fiscal year.

Cooper Companies Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.